Ares Capital Corporation Announces $0.48 Dividend for Q1 2026 Following Release of 2025 Financial Results

2026-02-04|

Ares Capital Corporation Announces $0.48 Dividend for Q1 2026 Following Release of 2025 Financial Results

by GOAI

Share To

Ares Capital Corporation released its financial results for the fiscal year ending December 31, 2025, and announced a dividend of $0.48 per share for the first quarter of 2026. The company disclosed these updates on February 4, 2026, providing shareholders with details regarding its performance and upcoming payout.

The financial report highlighted key metrics from the company’s operations during 2025. Ares Capital Corporation also confirmed that the declared dividend will be distributed to eligible shareholders in accordance with its established schedule. Further information about the company’s earnings and dividend policy is available through official channels.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: February 4, 2026

Author

GOAI

LATEST

Lilly Acquires Orna Therapeutics in $2.4B to Scale In Vivo CAR-T Cell Therapies

2026-02-10

South African Patent Office Grants Manganese X Energy Corp. Patent for High-Purity Manganese Processing Technology

2026-02-10

Study Explores Impact of Symptoms on Health-Related Quality of Life in Older Swedish Men

2026-02-10

Study Finds Gaps in Support Systems for Parents Using At-Home Medical Devices for Children with Complex Needs

2026-02-10

Radiopharmaceutical Industry Faces Talent Shortage Amid Rapid Expansion

2026-02-10

FTI Consulting Expands Middle East Healthcare Advisory with Two Senior Hires

2026-02-09

Diego De Giorgi Appointed Head of EMEA at Apollo Global Management

2026-02-09

EVENT

2026-02-09

World Health Expo Dubai

Dubai Exhibition Centre, Dubai

2026-02-17

BIO Asia 2026 (Life Science Partnerships)

Hyderabad, India

2026-02-24

Rare Disease Week on Capitol Hill (Policy and Advocacy)

Capitol Hill, Washington, D.C.

2026-03-09

HIMSS26 (Digital Health & Hospital IT)

Las Vegas, Nevada

2026-03-10

Bioprocessing Summit Europe (Biomanufacturing Trends)

Barcelona, Spain

2026-03-23

DCAT Week

New York, USA

Cookie	Duration	Description
cookielawinfo-checbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

GENE ONLINE|News &
Opinion
Blog